Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-12-03 | Nodules 1 | ETA2023

Malignancy risk stratification and subcategorization of intermediate suspicion thyroid nodules: A retrospective multicenter validation study

Lee Boeun , Gyu Na Dong , Kim Ji-Hoon

Objective: To determine whether the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS) 4 nodules can be subcategorized by ultrasonography (US)-based stratification of malignancy risk, and to evaluate the diagnostic performance of the modified biopsy criterion based on the subcategorization of the K-TIRADS 4 category in a multicenter cohort.Materials and Methods: A total of 1,541 K-TIRADS 4 nodules (≥ 1 cm) with final diagnoses were include...

ea0092op-08-03 | Oral Session 8: Hypothyrodism / Nodules | ETA2023

Diagnostic performance of ultrasound-based risk stratification systems for thyroid nodules: a systematic review and meta-analysis

Joo Leehi , Kyoung Lee Min , Ye Lee Ji , Ju Ha Eun , Gyu Na Dong

Objectives: The aim of this study was to evaluate the diagnostic performance of biopsy criteria in four society ultrasonography (US)-based risk stratification systems (RSSs) or thyroid imaging reporting and data system (TIRADS) including the 2021 Korean (K)-TIRADS for thyroid nodules.Methods: Ovid-Medline, EMBASE, Cochrane, and KoreaMed databases were searched and other eligible articles by manual search were included to identify original articles invest...

ea0092ps2-18-08 | Treatment 1 | ETA2023

Clinical practice guidelines for radiofrequency ablation of benign thyroid nodules and malignant thyroid cancers: A systematic review

Kyoung Lee Min , Hwan Baek Jung , Lyung Jung So , Gyu Na Dong

Objectives: Radiofrequency ablation (RFA) is considered an alternative treatment for benign thyroid nodules and malignant thyroid cancers. There were various clinical practice guidelines from international societies for ablation of benign thyroid nodules. Recently, RFA is becoming a promising treatment choice for recurrence thyroid cancer, and RFA is suggested as a minimally invasive treatment for low-risk papillary thyroid microcarcinoma (PTMC). Several international societie...